Clinical Trial Update: The Effect of Methylphenidate on Non-motor Symptoms and Postural Control in Parkinson's Disease. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating methylphenidate for non-motor symptoms and postural control in Parkinson's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Laval University | Conditions: Parkinson's Disease | Phase 4 | Status: TERMINATED